P131-0363 Screening compound: N-(cyclohexylmethyl)-3-[3-(pyrrolidin-1-yl)pyrazin-2-yl]benzamide

P131-0363 Screening compound: N-(cyclohexylmethyl)-3-[3-(pyrrolidin-1-yl)pyrazin-2-yl]benzamide
P131-0363 Screening compound: N-(cyclohexylmethyl)-3-[3-(pyrrolidin-1-yl)pyrazin-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P131-0363
N-(cyclohexylmethyl)-3-[3-(pyrrolidin-1-yl)pyrazin-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P131-0363

Molecular Formula

C22H28N4O (C22 H28 N4 O)

Compound Name

N-(cyclohexylmethyl)-3-[3-(pyrrolidin-1-yl)pyrazin-2-yl]benzamide

IUPAC name

N-(cyclohexylmethyl)-3-[3-(pyrrolidin-1-yl)pyrazin-2-yl]benzamide

SMILES

O=C(c1cc(-c2nccnc2N2CCCC2)ccc1)NCC1CCCCC1

InChI

InChI=1S/C22H28N4O/c27-22(25-16-17-7-2-1-3-8-17)19-10-6-9-18(15-19)20-21(24-12-11-23-20)26-13-4-5-14-26/h6,9-12,15,17H,1-5,7-8,13-14,16H2,(H,25,27)

InChI Key

VTRHUMTWFUPLTP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27566195

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

364.49

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.186

Distribution Coefficient, logD

4.186

Water Solubility, LogSw

-4.29

Polar Surface Area

47.190

Acid Dissociation Constant (pKa)

13.69

Base Dissociation Constant (pKb)

2.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

P131-0363 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P131-0363 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P131-0363?
Check Price and Availability of P131-0363, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P131-0363 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P131-0363
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P131-0363
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P131-0363 available by request